Search research articles
Contact Us
Filters
Showing results (331-340 of 346) with videos related to
Page
of 35
Sort By:
Physiologia Plantarum
|
April 25, 2023
Purple Rehmannia: Investigation of the activation of R2R3-MYB transcription factors involved in anthocyanin biosynthesis
Xin Zuo, Chunyan Miao, Mingming Li, et al.
Current Medicinal Chemistry
|
November 8, 2022
The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases
Zeqiang Ma, Shengnan Wang, Weiwei Miao, et al.
Integrative Cancer Therapies
|
June 10, 2022
Milk and Egg Are Risk Factors for Adverse Effects of Capecitabine-Based Chemotherapy in Chinese Colorectal Cancer Patients
Jinrong Xu, Zeshuai Lin, Jiani Chen, et al.
Cardiovascular Diabetology
|
February 2, 2013
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
Jun Lu, Beau Pontré, Stephen Pickup, et al.
BMC Cancer
|
May 20, 2023
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients
Bo Zhang, Xuetao Shi, Kai Cui, et al.
Frontiers in Pharmacology
|
April 21, 2025
Multi-tissue metabolomics analysis reveals susceptible factors for chemotherapy-induced hepatotoxicity in colorectal cancer patients
Huilin Xu, Mingming Li, Houshan Yao, et al.
BMC Gastroenterology
|
October 17, 2024
Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years
Zhibin Chang, Mingming Li, Zhicheng Sun, et al.
Biotechnology Journal
|
August 2, 2017
Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes
Qian Zhu, Mingming Li, Chuan Yan, et al.
Nature Communications
|
April 16, 2024
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial
Zhongchao Li, Jing Liu, Bo Zhang, et al.
BMC Cancer
|
May 7, 2025
Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial
Kugeluke Yalikun, Zhongchao Li, Jianxin Zhang, et al.
Page
of 35
Search research articles
Search
Showing results (331-340 of 346) with videos related to
Sort By:
Page
of 35
Physiologia Plantarum
|
April 25, 2023
Purple Rehmannia: Investigation of the activation of R2R3-MYB transcription factors involved in anthocyanin biosynthesis
Xin Zuo, Chunyan Miao, Mingming Li, et al.
Current Medicinal Chemistry
|
November 8, 2022
The Roles of Natural Alkaloids and Polyphenols in Lipid Metabolism: Therapeutic Implications and Potential Targets in Metabolic Diseases
Zeqiang Ma, Shengnan Wang, Weiwei Miao, et al.
Integrative Cancer Therapies
|
June 10, 2022
Milk and Egg Are Risk Factors for Adverse Effects of Capecitabine-Based Chemotherapy in Chinese Colorectal Cancer Patients
Jinrong Xu, Zeshuai Lin, Jiani Chen, et al.
Cardiovascular Diabetology
|
February 2, 2013
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
Jun Lu, Beau Pontré, Stephen Pickup, et al.
BMC Cancer
|
May 20, 2023
Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients
Bo Zhang, Xuetao Shi, Kai Cui, et al.
Frontiers in Pharmacology
|
April 21, 2025
Multi-tissue metabolomics analysis reveals susceptible factors for chemotherapy-induced hepatotoxicity in colorectal cancer patients
Huilin Xu, Mingming Li, Houshan Yao, et al.
BMC Gastroenterology
|
October 17, 2024
Clinical study on conversion therapy of hepatocellular carcinoma - summary and comparison of clinical data from a single center of consecutive four years
Zhibin Chang, Mingming Li, Zhicheng Sun, et al.
Biotechnology Journal
|
August 2, 2017
Directed Differentiation of Human Embryonic Stem Cells to Neural Crest Stem Cells, Functional Peripheral Neurons, and Corneal Keratocytes
Qian Zhu, Mingming Li, Chuan Yan, et al.
Nature Communications
|
April 16, 2024
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial
Zhongchao Li, Jing Liu, Bo Zhang, et al.
BMC Cancer
|
May 7, 2025
Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial
Kugeluke Yalikun, Zhongchao Li, Jianxin Zhang, et al.
Page
of 35